Wegovy weight loss pill gets US FDA nod
Digest more
Eli Lilly (LLY) stock is in focus as the company posts late-stage trial data to indicate that its obesity pill orforglipron offers super weight-loss maintenance. Read more here.
So the, the question we're investigating in this study is whether the use of GLP-1 receptor agonists, which is *** medication for weight loss and diabetes, um, is associated with *** lower risk of obesity-associated cancers as compared to DPP-4 inhibitors ...
(CNN) — The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to request global regulatory approval this year, the company said Tuesday. The only semaglutide pill that’s currently available ...